載入...
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
Na minha lista:
| 發表在: | Blood Cancer J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8116334/ https://ncbi.nlm.nih.gov/pubmed/33980831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00478-4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|